Look deeper dumbo and I believe you will find that OXBT is about to lose all rights to Levo fro Orion. The whole structure stunk from the very beginning and I think the house of cards is falling down as we speak.
You can't be serious can you? Are you that stupid? This company has changed names several times now, SYBD, OXBO, OXBT. Each change in my opinion was for one reason and one reason only. It was an attempt to make it harder for investors to tie together the long string of failures and border line if not outright fraud.
This is fantastic: this sort of analysis is exactly what I’ve been looking at doing myself. Thank you and great work.
Check out SSR they just came out with an email report on OXBT, pretty interesting report. If you're a trader you should sign up to their free newsletter regardless. Their last downgrade was on PLUG, next day it tanked 40%...LOL
as of now Oxycyte has no priority with new management, somehow disappointed that they do not push Oxycyte with all its potential but Levo... on its own will justify a stock price of over $50 when product is approved. patient enrollment is imminent and this makes OXBT a phase 3 company. With over $50 million on the account the "going concern" should be gone by now. They have to deliver and perform now and i hope many more shareholder breathe down their neck..
I am, since I don't swing the type of money you have, I'm planning on writing covered calls when it spikes to generate more cash to accumulate more shares. I think it will be awhile before it takes off so that should be a safe strategy.
And that the first patients will be enrolled soon. Other than that I didn't see anything new. I'm kind of disappointed that there have been no updates on Oxycyte. I figured by now they would have submitted a U.S. trial protocol to the FDA to resume phase IIB. It seems they are only focused on LEVO now, which isn't a bad thing, I just think Oxycyte is the blockbuster.